We describe the case of a child affected by acute lymphoblastic been treated according to a BFM-like ALL protocol. At time leukaemia who received adoptive immunotherapy after cord of transplantation, the child also presented a costal erosion blood transplantation (CBT). The patient, transplanted in associated with lung nodular lesions, which a biopsy demonsecond relapse resistant to chemotherapy, still showed lung strated to be of leukaemic origin (Figure 1a ). Conditioning and costal leukaemic nodular lesions 2 months after CBT. For regimen comprised: fractionated total body irradiation (12 Gy this reason, three infusions of donor peripheral blood leukocytes 1 ؋ 10 7 /kg each were administered on days ؉60, ؉80 and in six fractions over 3 days), thiotepa (10 mg/kg in two divided ؉100. The procedure was well tolerated by both patient and doses), and cyclophosphamide (120 mg/kg over 2 days). 1 mg/kg/day for the first 21 days, and subsequently orally at months after CBT. This experience suggests that adoptive a dose of 4 mg/kg/day for 1 more month after transplant.
Introduction thawing in a 37°C bath, a 1:1 volume of Dextran was slowly added to CB. After a 5 min rest, 5% albumin solution was Cord blood transplantation (CBT) is being increasingly used slowly added before centrifugation at 300 g for 10 min. After to rescue patients undergoing myeloablative therapy.
1 Advanremoving the supernatant, cells were diluted in 5% albumin tages of CBT include ease and safety of haematopoietic stem solution and promptly infused. cell collection, low risk of viral contamination, and, at least
The number of mononuclear cells and granulocyte-macroin recipients of HLA-compatible sibling graft, reduced inciphage colony-forming units (CFU-GM) transferred per kilodence of graft-versus-host disease (GVHD).
gram of recipient body weight was 4.8 × 10 7 and 39 × 10 3 , The reported low incidence of GVHD 1 might, on the other respectively. The immediate post-transplant period was hand, represent a major drawback to the employment of cord uneventful and the patient experienced a complete recovery blood as a source of stem cells for allogeneic transplantation of haematopoiesis, the time needed to achieve more than in leukaemic patients. In fact, the role of allogeneic lympho-0.5 × 10 9 /l granulocytes and a platelet count higher than cytes in the control and/or eradication of malignancy is well 50 × 10 9 /l being 29 and 51 days, respectively. Karyotype established, and an absence of the GVHD-associated compoanalysis on marrow cells and peripheral blood lymphocytes, nent of graft-versus-leukaemia (GVL) activity could represent together with the study of genetic polymorphism of a variable a theoretical concern in leukaemic subjects given CBT. Morenumber of tandemly repeated short DNA sequences, docuover, the immaturity of infused cord blood lymphocytes 2,3 mented a complete donor chimerism by day +30 after CBT. could contribute further to the impairment of this critical
The child showed no sign or symptom of acute or chronic immune-mediated effect. In view of these considerations and of GVHD and this allowed the discontinuation of CsA therapy the ability of donor peripheral blood leukocyte infusions to on day +51. Bone marrow aspirate performed on day +50 restore a state of remission in patients with relapsed acute or demonstrated the presence of normal haematopoiesis without chronic leukaemia after bone marrow transplantation (BMT), [4] [5] [6] any atypical cell, and immunophenotype analysis could not we decided to employ donor leukocyte therapy after CBT with reveal the original clone. On the contrary, CT scan of the lung the aim of preventing malignancy recurrence in a child with documented the persistence of two small lesions evocative of acute lymphoblastic leukaemia (ALL).
persistent localization of leukaemia (Figure 1b) . In view of the following considerations: (1) the advanced disease status of the patient at time of CBT; (2) the post-transplant persistence Case report of lung nodular lesions; (3) concern about the ability of cord blood lymphocytes to display an effective GVL action; and (4) A 7-year-old boy affected by ALL with T cell immunophenothe absence of GVHD after CBT, we decided to infuse donor type in second marrow relapse resistant to chemotherapy was leukocytes as consolidation of transplant-induced marrow given a CBT from his HLA-identical sibling. The patient had remission and as a means to eradicate the lung lesions. After obtaining parental informed written consent, donorderived leukocyte infusions were performed on days +60, +80
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